Abstract:Settings and Design: A retrospective study which analyzed the data of female patients attending a tertiary care center in National Capital Territory for the treatment of endometrial cancer.Materials and Methods: Eighty-six histopathologically confirmed cases of carcinoma endometrium were taken from January 2016 to December 2019. Detailed information was collected regarding patient's case history, sociodemographic data (age of presentation, occupation, religion, residence, and substance addiction), clinical presentation, diagnostic and therapeutic procedures, and known risk factors (age at menarche and menopause, parity, obesity, use of oral contraceptive pills, hormone replacement therapy, and comorbidities such as hypertension and diabetes).Statistical Analysis Used: After analysis, results were presented as mean ± standard deviation and frequency.Results: Eighty-six percent of the patients (n = 73) were in the age group of 40-70 years; the mean age of the patients at diagnosis of endometrial cancer was 54 years. Eighty-one percent (n = 70) of the patients were from urban areas. Sixty-seven percent of the females (n = 54) were Hindu. All the patients were housewives with nonsedentary lifestyles. Most patients (88%; n = 76) presented with bleeding per vaginum. Fifty-nine percent (n = 51) had stage I disease, followed by 15% (n = 13) with stage II, 14% (n = 12) with stage III, and 12% (n = 10) with stage IV disease. Eighty-two percent (n = 72) of the patients had endometrioid carcinoma. Other less common variants were mixed Mullerian malignant tumor, squamous, adenosquamous, serous, and endometrioid stromal. Forty-four percent (n = 38), 39% (n = 34), and 16% (n = 14) of the patients had grade I, grade II, and grade III tumor, respectively. 53.5% of the cases (n = 46) had >50% myometrial invasion at the time of presentation. Eighty-two percent (n = 71) of the patients were postmenopausal. The mean age at menarche and menopause was 13 years and 47 years, respectively. Fifteen percent (n = 13) of the females were nulliparous. Forty-six percent (n = 40) of the patients were overweight. Most patients (82%) had no history of addiction. Twenty-five percent (n = 22) of the patients had hypertension, and 27% (n = 23) has diabetes as comorbidity.Conclusions: The incidence of endometrium cancer is showing a steady rise in the recent past. Early age of menarche, late age of menopause, nulliparity, obesity, and diabetes mellitus are well-documented risk factors for uterine cancer. Better outcome and control of disease is possible by understanding of endometrial cancer etiology, risk factors, and its preventive measures. Thus, a robust screening program is warranted to detect the disease in early stage and for increased survival.

Clinicopathological Analysis of Carcinoma Endometrium at a Tertiary Care Centre in Chennai – A Retrospective Study

A Clinicopathologic and Prognostic Analysis of 115 Cases of Endometrial Carcinoma

High-Grade Endometrial Cancer—Behaviour and Outcomes at a Tertiary Cancer Centre

Compliance of Surgical Care in Patients with Carcinoma Endometrium in a Tertiary Care Centre in South India, to European Society of Gynaecologic Oncology (ESGO) Quality Indicators

Immunohistochemical Analysis Of Novel Biomarkers Cyclin D1, p53 And Ki67 In Endometrial Carcinoma: Clinicopathological Significance And Prognostic Value

Preoperative and Intraoperative Assessment of Myometrial Invasion in Patients with FIGO Stage I Non-Endometrioid Endometrial Carcinoma—a Large-Scale, Multi-Center, and Retrospective Study

Pattern of care and clinical outcome of patients with carcinoma endometrium and the impact of central histopathological review on management: A tertiary cancer centre experience

Epidemiological characteristics of endometrial cancer patients treated at a tertiary health center in National Capital Territory of India

The clinico pathological features and survival in serous endometrial cancers

[Combined Treatment and Prognostic Factors for Stage III and IV Endometrial Carcinoma].

Overall and progression-free survival in endometrial carcinoma: A single-center retrospective study of patients treated between 2000-2018

Clinical analysis of treatment outcome for 559 patients with endometrial cancer

Survival analyses of patients with non-endometrioid endometrial carcinoma

Early oncological outcomes and accuracy of risk stratification and tailoring surgical staging based on preoperative histology, Ca125 and MRI in endometrial cancer: a prospective cohort study

Systematic Lymphadenectomy and Oncological Outcomes of Women With Apparent Early-Stage Clear Cell Carcinoma of the Endometrium: A Multi-Institutional Cohort Study

Clinical analysis of treatment outcome for 435 patients with endometrial cancer

Rarely Observed Histopathological Subtypes of Endometrial Malignant Tumors in a Tertiary Care Center: A Case Series

Role of Multiparametric MRI in the Preoperative Evaluation of Endometrial Carcinoma: A Cross-Sectional Study

Clear Cell Carcinoma of the Endometrium: Evaluation of Prognostic Parameters in 27 Cases

[Predictors of Recurrence and Prognosis in Patients with Stage I and II Endometrial Carcinoma].

Survival outcomes of epithelial ovarian cancer treated at a tertiary-level hospital in India